News

Asthma is a chronic lung condition that causes airway inflammation and affects approximately 262 million people worldwide1. Typical symptoms include: Wheezing, Breathlessness, Chest tightness, Coughing. When airways are inflamed, breathing can become difficult. Recent Asthma + Lung UK research found...

Intermedical UK proudly delivers the 3,000th NObreath® FeNO device to the UK market. Bedfont® Scientific Limited, a medical device manufacturer based in Kent, with over 49 years’ experience in the breath analysis industry, was pleased to support its UK distributor,...

Innovative NObreath® FeNO device is the allergists' device of choice in the USA. coVita™ LLC, a leader in advanced breath analysis and diagnostic solutions, serves as the U.S. distributor for the innovative NObreath® Fractional Exhaled Nitric Oxide (FeNO) device from...

Smokerlyzer®, Gastrolyzer®, and NObreath® devices on show at the world’s largest healthcare event. Bedfont® Scientific, world leaders in breath analysis, with over 49 years of experience in the medical breath analysis industry, is thrilled to be showing its innovative devices...

January marks the start of a new year, with many people using this time as a fresh start and the perfect time to set health-improving goals. A study in 2024 found that January is the most popular month of the...

Bedfont® is recognised for putting people first and scoops the AHM Health & Wellbeing Award. Bedfont® Scientific Limited, an innovative MedTech company that has just celebrated its 49th anniversary, is thrilled to have won the All Health Matters (AHM) Health...